Trial Profile
Exercise induced bronchoconstriction in children – a single dose of montelukast as alternative to regular daily doses. Anstrengelsesudløst astma hos børn – enkeltdosering af montelukast som alternativ til fast daglig dosering.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 18 Jun 2020
Price :
$35
*
At a glance
- Drugs Montelukast (Primary)
- Indications Exercise-induced asthma
- Focus Therapeutic Use
- 18 Jun 2020 Status changed from recruiting to discontinued.
- 12 Oct 2012 New trial record